Loading…
Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres
ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties...
Saved in:
Published in: | Drug development and industrial pharmacy 2007-04, Vol.33 (4), p.485-491 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3 |
container_end_page | 491 |
container_issue | 4 |
container_start_page | 485 |
container_title | Drug development and industrial pharmacy |
container_volume | 33 |
creator | Piao, Ming Guan Kim, Jeong-Hoon Kim, Jong Oh Lyoo, Won Seok Lee, Mann Hyung Yong, Chul Soon Choi, Han-Gon |
description | ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties such as shape, size, drug-loading efficiency and dissolution were investigated. The pharmacokinetic study of piroxicam-loaded hyaluronic micropheres in rats was then performed compared to piroxicam powder. The piroxicam-loaded hyaluronic microspheres, spherical in shape, had the geometric mean diameters of about 1.5 μm and drug loading efficiency of about 90%, irrespective of ratio of piroxicam sodium hyaluronate PEG. The hyaluronic microspheres containing PEG gave significantly higher dissolution rates of drug than did piroxicam powder, PEG-based solid dispersion system and hyaluronic microspheres without PEG, suggesting that the hyaluronic microsphere with sodium hyaluronate and PEG was more useful for improving the dissolution rate of poorly water soluble piroxicam. The piroxicam-loaded hyaluronic microcapsule composed of (piroxicam sodium hyaluronate PEG; 2: 20: 1) gave about threefold improved dissolution of drug in water for 4 h compared to piroxicam powder. It showed higher plasma concentrations of drug compared to piroxicam powder. It gave significantly higher AUC and faster Tmax of piroxicam than did piroxicam powder. In particular, the AUC of piroxicam from hyaluronic microsphere was about twofold higher than that from piroxicam powder, suggesting that it could enhance the oral bioavailability of piroxicam. Thus, the hyaluronic microsphere developed using spray-drying technique with sodium hyaluronate and PEG was a more effective oral dosage form for poorly water soluble piroxicam. |
doi_str_mv | 10.1080/03639040600865223 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_03639040600865223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70526133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EokvhAbggX-AWGNt1nAguUBWKVChCcI4mzljryokXOwHy9ni1iyqE1NNoNN8_mvkYeyrgpYAGXoGqVQtnUAM0tZZS3WMboSVU2tTyPtvs51UB9Al7lPMNgJCt1g_ZiTBaqtJt2OeLaYuTpYFfJwz8nY_4E33A3gc_rzw6_sWn-NtbHLmf-FecM-9XfrliWFKccCb-ydsU825LifJj9sBhyPTkWE_Z9_cX384vq6vrDx_P315VVgPM1dA2PSnr2t4Yqci1rnxgezGgNGZwQkgwsm2FNFLTmSXqUZMGdOgG0QtSp-zFYe8uxR8L5bkbfbYUAk4Ul9wZ0LIWShVQHMD9jTmR63bJj5jWTkC3l9j9J7Fknh2XL_1Iw23iaK0Az48AZovBpWLQ51uuaVRjDBTuzYHzk4tpxF8xhaGbcQ0x_Q2pu-54_U98SxjmrcVE3U1c0lQE3_HFHzsFnvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70526133</pqid></control><display><type>article</type><title>Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><source>BSC - Ebsco (Business Source Ultimate)</source><creator>Piao, Ming Guan ; Kim, Jeong-Hoon ; Kim, Jong Oh ; Lyoo, Won Seok ; Lee, Mann Hyung ; Yong, Chul Soon ; Choi, Han-Gon</creator><creatorcontrib>Piao, Ming Guan ; Kim, Jeong-Hoon ; Kim, Jong Oh ; Lyoo, Won Seok ; Lee, Mann Hyung ; Yong, Chul Soon ; Choi, Han-Gon</creatorcontrib><description>ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties such as shape, size, drug-loading efficiency and dissolution were investigated. The pharmacokinetic study of piroxicam-loaded hyaluronic micropheres in rats was then performed compared to piroxicam powder. The piroxicam-loaded hyaluronic microspheres, spherical in shape, had the geometric mean diameters of about 1.5 μm and drug loading efficiency of about 90%, irrespective of ratio of piroxicam sodium hyaluronate PEG. The hyaluronic microspheres containing PEG gave significantly higher dissolution rates of drug than did piroxicam powder, PEG-based solid dispersion system and hyaluronic microspheres without PEG, suggesting that the hyaluronic microsphere with sodium hyaluronate and PEG was more useful for improving the dissolution rate of poorly water soluble piroxicam. The piroxicam-loaded hyaluronic microcapsule composed of (piroxicam sodium hyaluronate PEG; 2: 20: 1) gave about threefold improved dissolution of drug in water for 4 h compared to piroxicam powder. It showed higher plasma concentrations of drug compared to piroxicam powder. It gave significantly higher AUC and faster Tmax of piroxicam than did piroxicam powder. In particular, the AUC of piroxicam from hyaluronic microsphere was about twofold higher than that from piroxicam powder, suggesting that it could enhance the oral bioavailability of piroxicam. Thus, the hyaluronic microsphere developed using spray-drying technique with sodium hyaluronate and PEG was a more effective oral dosage form for poorly water soluble piroxicam.</description><identifier>ISSN: 0363-9045</identifier><identifier>EISSN: 1520-5762</identifier><identifier>DOI: 10.1080/03639040600865223</identifier><identifier>PMID: 17523012</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Administration, Oral ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics ; Area Under Curve ; Bbioavailability ; Biological and medical sciences ; Biological Availability ; Dissolution ; General pharmacology ; Hyaluronic Acid - chemistry ; In Vitro Techniques ; Male ; Medical sciences ; Microspheres ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Piroxicam ; Piroxicam - chemistry ; Piroxicam - pharmacokinetics ; Polyethylene glycol ; Polyethylene Glycols - chemistry ; Powders ; Rats ; Rats, Wistar ; Sodium hyaluronate ; Solubility ; Technology, Pharmaceutical</subject><ispartof>Drug development and industrial pharmacy, 2007-04, Vol.33 (4), p.485-491</ispartof><rights>2007 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2007</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3</citedby><cites>FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18838770$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17523012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piao, Ming Guan</creatorcontrib><creatorcontrib>Kim, Jeong-Hoon</creatorcontrib><creatorcontrib>Kim, Jong Oh</creatorcontrib><creatorcontrib>Lyoo, Won Seok</creatorcontrib><creatorcontrib>Lee, Mann Hyung</creatorcontrib><creatorcontrib>Yong, Chul Soon</creatorcontrib><creatorcontrib>Choi, Han-Gon</creatorcontrib><title>Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres</title><title>Drug development and industrial pharmacy</title><addtitle>Drug Dev Ind Pharm</addtitle><description>ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties such as shape, size, drug-loading efficiency and dissolution were investigated. The pharmacokinetic study of piroxicam-loaded hyaluronic micropheres in rats was then performed compared to piroxicam powder. The piroxicam-loaded hyaluronic microspheres, spherical in shape, had the geometric mean diameters of about 1.5 μm and drug loading efficiency of about 90%, irrespective of ratio of piroxicam sodium hyaluronate PEG. The hyaluronic microspheres containing PEG gave significantly higher dissolution rates of drug than did piroxicam powder, PEG-based solid dispersion system and hyaluronic microspheres without PEG, suggesting that the hyaluronic microsphere with sodium hyaluronate and PEG was more useful for improving the dissolution rate of poorly water soluble piroxicam. The piroxicam-loaded hyaluronic microcapsule composed of (piroxicam sodium hyaluronate PEG; 2: 20: 1) gave about threefold improved dissolution of drug in water for 4 h compared to piroxicam powder. It showed higher plasma concentrations of drug compared to piroxicam powder. It gave significantly higher AUC and faster Tmax of piroxicam than did piroxicam powder. In particular, the AUC of piroxicam from hyaluronic microsphere was about twofold higher than that from piroxicam powder, suggesting that it could enhance the oral bioavailability of piroxicam. Thus, the hyaluronic microsphere developed using spray-drying technique with sodium hyaluronate and PEG was a more effective oral dosage form for poorly water soluble piroxicam.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</subject><subject>Area Under Curve</subject><subject>Bbioavailability</subject><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Dissolution</subject><subject>General pharmacology</subject><subject>Hyaluronic Acid - chemistry</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microspheres</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Piroxicam</subject><subject>Piroxicam - chemistry</subject><subject>Piroxicam - pharmacokinetics</subject><subject>Polyethylene glycol</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Powders</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Sodium hyaluronate</subject><subject>Solubility</subject><subject>Technology, Pharmaceutical</subject><issn>0363-9045</issn><issn>1520-5762</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhi0EokvhAbggX-AWGNt1nAguUBWKVChCcI4mzljryokXOwHy9ni1iyqE1NNoNN8_mvkYeyrgpYAGXoGqVQtnUAM0tZZS3WMboSVU2tTyPtvs51UB9Al7lPMNgJCt1g_ZiTBaqtJt2OeLaYuTpYFfJwz8nY_4E33A3gc_rzw6_sWn-NtbHLmf-FecM-9XfrliWFKccCb-ydsU825LifJj9sBhyPTkWE_Z9_cX384vq6vrDx_P315VVgPM1dA2PSnr2t4Yqci1rnxgezGgNGZwQkgwsm2FNFLTmSXqUZMGdOgG0QtSp-zFYe8uxR8L5bkbfbYUAk4Ul9wZ0LIWShVQHMD9jTmR63bJj5jWTkC3l9j9J7Fknh2XL_1Iw23iaK0Az48AZovBpWLQ51uuaVRjDBTuzYHzk4tpxF8xhaGbcQ0x_Q2pu-54_U98SxjmrcVE3U1c0lQE3_HFHzsFnvc</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Piao, Ming Guan</creator><creator>Kim, Jeong-Hoon</creator><creator>Kim, Jong Oh</creator><creator>Lyoo, Won Seok</creator><creator>Lee, Mann Hyung</creator><creator>Yong, Chul Soon</creator><creator>Choi, Han-Gon</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres</title><author>Piao, Ming Guan ; Kim, Jeong-Hoon ; Kim, Jong Oh ; Lyoo, Won Seok ; Lee, Mann Hyung ; Yong, Chul Soon ; Choi, Han-Gon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</topic><topic>Area Under Curve</topic><topic>Bbioavailability</topic><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Dissolution</topic><topic>General pharmacology</topic><topic>Hyaluronic Acid - chemistry</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microspheres</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Piroxicam</topic><topic>Piroxicam - chemistry</topic><topic>Piroxicam - pharmacokinetics</topic><topic>Polyethylene glycol</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Powders</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Sodium hyaluronate</topic><topic>Solubility</topic><topic>Technology, Pharmaceutical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piao, Ming Guan</creatorcontrib><creatorcontrib>Kim, Jeong-Hoon</creatorcontrib><creatorcontrib>Kim, Jong Oh</creatorcontrib><creatorcontrib>Lyoo, Won Seok</creatorcontrib><creatorcontrib>Lee, Mann Hyung</creatorcontrib><creatorcontrib>Yong, Chul Soon</creatorcontrib><creatorcontrib>Choi, Han-Gon</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug development and industrial pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piao, Ming Guan</au><au>Kim, Jeong-Hoon</au><au>Kim, Jong Oh</au><au>Lyoo, Won Seok</au><au>Lee, Mann Hyung</au><au>Yong, Chul Soon</au><au>Choi, Han-Gon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres</atitle><jtitle>Drug development and industrial pharmacy</jtitle><addtitle>Drug Dev Ind Pharm</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>33</volume><issue>4</issue><spage>485</spage><epage>491</epage><pages>485-491</pages><issn>0363-9045</issn><eissn>1520-5762</eissn><abstract>ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties such as shape, size, drug-loading efficiency and dissolution were investigated. The pharmacokinetic study of piroxicam-loaded hyaluronic micropheres in rats was then performed compared to piroxicam powder. The piroxicam-loaded hyaluronic microspheres, spherical in shape, had the geometric mean diameters of about 1.5 μm and drug loading efficiency of about 90%, irrespective of ratio of piroxicam sodium hyaluronate PEG. The hyaluronic microspheres containing PEG gave significantly higher dissolution rates of drug than did piroxicam powder, PEG-based solid dispersion system and hyaluronic microspheres without PEG, suggesting that the hyaluronic microsphere with sodium hyaluronate and PEG was more useful for improving the dissolution rate of poorly water soluble piroxicam. The piroxicam-loaded hyaluronic microcapsule composed of (piroxicam sodium hyaluronate PEG; 2: 20: 1) gave about threefold improved dissolution of drug in water for 4 h compared to piroxicam powder. It showed higher plasma concentrations of drug compared to piroxicam powder. It gave significantly higher AUC and faster Tmax of piroxicam than did piroxicam powder. In particular, the AUC of piroxicam from hyaluronic microsphere was about twofold higher than that from piroxicam powder, suggesting that it could enhance the oral bioavailability of piroxicam. Thus, the hyaluronic microsphere developed using spray-drying technique with sodium hyaluronate and PEG was a more effective oral dosage form for poorly water soluble piroxicam.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><pmid>17523012</pmid><doi>10.1080/03639040600865223</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-9045 |
ispartof | Drug development and industrial pharmacy, 2007-04, Vol.33 (4), p.485-491 |
issn | 0363-9045 1520-5762 |
language | eng |
recordid | cdi_crossref_primary_10_1080_03639040600865223 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list); BSC - Ebsco (Business Source Ultimate) |
subjects | Administration, Oral Animals Anti-Inflammatory Agents, Non-Steroidal - chemistry Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics Area Under Curve Bbioavailability Biological and medical sciences Biological Availability Dissolution General pharmacology Hyaluronic Acid - chemistry In Vitro Techniques Male Medical sciences Microspheres Particle Size Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Piroxicam Piroxicam - chemistry Piroxicam - pharmacokinetics Polyethylene glycol Polyethylene Glycols - chemistry Powders Rats Rats, Wistar Sodium hyaluronate Solubility Technology, Pharmaceutical |
title | Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T12%3A05%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20Oral%20Bioavailability%20of%20Piroxicam%20in%20Rats%20by%20Hyaluronate%20Microspheres&rft.jtitle=Drug%20development%20and%20industrial%20pharmacy&rft.au=Piao,%20Ming%20Guan&rft.date=2007-04-01&rft.volume=33&rft.issue=4&rft.spage=485&rft.epage=491&rft.pages=485-491&rft.issn=0363-9045&rft.eissn=1520-5762&rft_id=info:doi/10.1080/03639040600865223&rft_dat=%3Cproquest_cross%3E70526133%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70526133&rft_id=info:pmid/17523012&rfr_iscdi=true |